1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Stem Cell Therapy Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Stem Cell Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Stem Cell Therapy Market Regional Analysis
6.2 Middle East & Africa Stem Cell Therapy Market Revenue 2020-2028 (US$ Million)
6.3 Middle East & Africa Stem Cell Therapy Market Forecast Analysis
7. Middle East & Africa Stem Cell Therapy Market Analysis – by Type
7.1 Adult Stem Cell Therapy
- 7.1.1 Overview
- 7.1.2 Adult Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Embryonic Stem Cell Therapy
- 7.2.1 Overview
- 7.2.2 Embryonic Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Induced Pluripotent Stem Cell Therapy
- 7.3.1 Overview
- 7.3.2 Induced Pluripotent Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.4 Other Stem Cell Therapy
- 7.4.1 Overview
- 7.4.2 Other Stem Cell Therapy: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Middle East & Africa Stem Cell Therapy Market Analysis – by Treatment
8.1 Allogeneic
- 8.1.1 Overview
- 8.1.2 Allogeneic: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Autologous
- 8.2.1 Overview
- 8.2.2 Autologous: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Middle East & Africa Stem Cell Therapy Market Analysis – by Application
9.1 Musculoskeletal
- 9.1.1 Overview
- 9.1.2 Musculoskeletal: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Dermatology
- 9.2.1 Overview
- 9.2.2 Dermatology: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Cardiology
- 9.3.1 Overview
- 9.3.2 Cardiology: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Drug Discovery & Development
- 9.4.1 Overview
- 9.4.2 Drug Discovery & Development: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.5 Other Applications
- 9.5.1 Overview
- 9.5.2 Other Applications: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. Middle East & Africa Stem Cell Therapy Market Analysis – by End User
10.1 Hospitals & Specialty Clinics
- 10.1.1 Overview
- 10.1.2 Hospitals & Specialty Clinics: Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.2 Academic & Research Institutes
- 10.2.1 Overview
- 10.2.2 Academic & Research Institutes : Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
11. Middle East & Africa Stem Cell Therapy Market – Middle East and Africa Analysis
11.1 Overview
11.2 Middle East and Africa
- 11.2.1 Middle East & Africa Stem Cell Therapy Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 11.2.1.1 Middle East & Africa Stem Cell Therapy Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 South Africa:
Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 South Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by Type
- 11.2.1.1.2 South Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by Treatment
- 11.2.1.1.3 South Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by Application
- 11.2.1.1.4 South Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by End User
- 11.2.1.2 Saudi Arabia:
Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Saudi Arabia: Middle East & Africa Stem Cell Therapy Market Breakdown, by Type
- 11.2.1.2.2 Saudi Arabia: Middle East & Africa Stem Cell Therapy Market Breakdown, by Treatment
- 11.2.1.2.3 Saudi Arabia: Middle East & Africa Stem Cell Therapy Market Breakdown, by Application
- 11.2.1.2.4 Saudi Arabia: Middle East & Africa Stem Cell Therapy Market Breakdown, by End User
- 11.2.1.3 UAE:
Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 UAE: Middle East & Africa Stem Cell Therapy Market Breakdown, by Type
- 11.2.1.3.2 UAE: Middle East & Africa Stem Cell Therapy Market Breakdown, by Treatment
- 11.2.1.3.3 UAE: Middle East & Africa Stem Cell Therapy Market Breakdown, by Application
- 11.2.1.3.4 UAE: Middle East & Africa Stem Cell Therapy Market Breakdown, by End User
- 11.2.1.4 Rest of Middle East and Africa:
Middle East & Africa Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by Type
- 11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by Treatment
- 11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by Application
- 11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Stem Cell Therapy Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Lonza Group AG
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Pluri Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Smith & Nephew Plc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 TiGenix NV (Takeda Pharmaceutical Company Limited)
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations